What is Advanced BioNutrition?
Founded in 2001 and headquartered in Columbia, Maryland, Advanced BioNutrition (ABN) operates as a specialized technology provider focused on the stabilization and delivery of sensitive bioactives. The company leverages a multidisciplinary research team—comprising biologists, chemists, food scientists, and engineers—to solve complex formulation challenges for enterprise partners. ABN's core value proposition lies in its ability to adapt proprietary delivery platforms to improve the efficacy and shelf-life of products within the human health, nutrition, and biopharmaceutical sectors. By bridging the gap between raw scientific innovation and commercial application, ABN has established itself as a vital partner for organizations seeking to enhance product performance through sustainable, science-backed methodologies.
How much funding has Advanced BioNutrition raised?
Advanced BioNutrition has raised a total of $11.4M across 5 funding rounds:
Unspecified
$1M
Series A
$2.5M
Series B
$7.5M
Debt
$150K
Debt
$280K
Unspecified (2002): $1M with participation from Sherbrooke Capital
Series A (2003): $2.5M led by Sherbrooke Capital
Series B (2005): $7.5M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Debt (2021): $280K backed by PPP
Key Investors in Advanced BioNutrition
Sherbrooke Capital
A venture capital firm dedicated to providing growth and expansion capital to emerging companies within the healthy, active, and sustainable living markets.
PPP
Public-Private Partnership
What's next for Advanced BioNutrition?
With the recent influx of $280K, Advanced BioNutrition is well-positioned to accelerate its R&D initiatives and expand its footprint in the biopharma and agricultural markets. The company's strategic roadmap likely involves deepening its intellectual property portfolio and scaling its manufacturing capabilities to meet the rising demand for high-performance bioactive delivery systems. As the industry shifts toward more sustainable and precise formulation standards, ABN's focus on collaborative, customer-centric innovation will be pivotal in maintaining its competitive advantage. Future growth will likely be driven by the commercialization of new stabilization technologies that address the evolving regulatory and performance requirements of global health and nutrition brands.
See full Advanced BioNutrition company page
